The Urology Cancer Center at Saint Francis Hospital – Memphis is a new specialized program designed for the diagnosis and treatment of urological cancers including both prostate and bladder cancer.
Nurse Navigator for the center, Gail Winkler, is specifically trained and experienced in helping cancer patients, their families and caregivers coordinate
medical and psychosocial care. As a certified oncology nurse, she is a key player on your team, providing knowledgeable support, compassion and encouragement through every step of your cancer journey.
For more information contact Gail Winkler at the Urology Cancer Center at Saint Francis 901-765-1059 or [email protected].
Benefits of a Nurse Navigator:
- Guide you through the healthcare system
- Provide information and education
- Coordinate tests and services
- Facilitate communication with your medical team
- Help you track and get to appointments
- Direct you to local resources and support
- Ensure that your questions and concerns on clinical issues are resolved
- Advocate for you during every phase of treatment
Saint Francis Hospital-Memphis offers the newest technology for the diagnosis of prostate cancer:
MRI / Ultrasound fusion – guided prostate biopsy offers a comprehensive solution with a cutting edge imaging option for many patients with elevated and/or rising PSA levels. Saint Francis Hospital – Memphis is the first to bring
this powerful solution to patients in the mid-south. Prostate MRI images taken can potentially identify specific areas within the gland that are suspicious and require further evaluation. Performing this biopsy with the MRI / Ultrasound fusion is
able to target the suspicious areas or lesions.
Bladder cancer is three times more common in men than women and is the fourth most common cancer (and second most common urologic cancer) found in men in the United States. At Saint Francis Hospital – Memphis, we offer the latest technology
to help detect and diagnose bladder cancer.
What is a Blue Light Cystoscopy with Cysview?
Blue Light Cystoscopy with Cysview is a technology that significantly improves the detection of nonmuscle invasive papillary cancer of the bladder as an adjunct to white light compared to traditional whitelight cystoscopy alone. Cysview (hexaminolevulinate
HCl) is an imaging solution that is delivered into the bladder and is absorbed by cancerous tissue. The doctor performs the cystoscopy by using both white light and blue light. When the doctor switches to blue light, it highlights cancerous tumors
and makes them more visible. Using Blue Light Cystoscopy with Cysview in conjunction with white light allows the physician to see more tumors than with standard white light cystoscopy alone
Can Anyone Get Blue-Light Cystoscopy with Cysview?
Blue-Light Cystoscopy with Cysview is recommended for anyone whose doctor suspects or knows that his or her patient has bladder cancer lesions based on a previous cystoscopy
What is a standard cystoscopy?
Standard cystoscopy is a test that allows your doctor to look directly inside your bladder with a scope. A cystoscopy may be used to help find the cause of symptoms, to treat or monitor conditions. Cystoscopy lets the doctor inspect your bladder lining
very closely for any abnormal growths or suspicious areas. The entire procedure is done under standard white light.